| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wolk Joseph J | Exec VP, CFO | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK | /s/ Joleen Morgan, as attorney-in-fact for Joseph J. Wolk | 18 Feb 2026 | 0001744564 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Common Stock | Options Exercise | $0 | +37,463 | +268% | $0.000000 | 51,463 | 13 Feb 2026 | Direct | F1 |
| transaction | JNJ | Common Stock | Tax liability | $3,900,083 | -15,948 | -31% | $244.55 | 35,515 | 13 Feb 2026 | Direct | F2 |
| transaction | JNJ | Common Stock | Options Exercise | $0 | +1,779 | +5% | $0.000000 | 37,294 | 13 Feb 2026 | Direct | F3 |
| transaction | JNJ | Common Stock | Tax liability | $123,987 | -507 | -1.4% | $244.55 | 36,787 | 13 Feb 2026 | Direct | F4 |
| transaction | JNJ | Common Stock | Options Exercise | $0 | +1,971 | +5.4% | $0.000000 | 38,758 | 15 Feb 2026 | Direct | F5 |
| transaction | JNJ | Common Stock | Tax liability | $208,880 | -858 | -2.2% | $243.45 | 37,900 | 15 Feb 2026 | Direct | F4 |
| transaction | JNJ | Common Stock | Options Exercise | $0 | +1,878 | +5% | $0.000000 | 39,778 | 15 Feb 2026 | Direct | F6 |
| transaction | JNJ | Common Stock | Tax liability | $198,899 | -817 | -2.1% | $243.45 | 38,961 | 15 Feb 2026 | Direct | F4 |
| transaction | JNJ | Common Stock | Options Exercise | $2,225,606 | +19,241 | +49% | $115.67 | 58,202 | 17 Feb 2026 | Direct | |
| transaction | JNJ | Common Stock | Sale | $4,675,371 | -19,241 | -33% | $242.99 | 38,961 | 17 Feb 2026 | Direct | F7 |
| transaction | JNJ | Common Stock | Options Exercise | $1,562,668 | +12,066 | +31% | $129.51 | 51,027 | 17 Feb 2026 | Direct | |
| transaction | JNJ | Common Stock | Sale | $2,930,469 | -12,066 | -24% | $242.87 | 38,961 | 17 Feb 2026 | Direct | F8 |
| transaction | JNJ | Common Stock | Options Exercise | $4,404,949 | +33,386 | +86% | $131.94 | 72,347 | 17 Feb 2026 | Direct | |
| transaction | JNJ | Common Stock | Sale | $8,104,452 | -33,386 | -46% | $242.75 | 38,961 | 17 Feb 2026 | Direct | F9 |
| transaction | JNJ | Common Stock | Sale | $6,057,535 | -24,961 | -64% | $242.68 | 14,000 | 17 Feb 2026 | Direct | F10 |
| holding | JNJ | Common Stock | 68,835 | 13 Feb 2026 | By SLAT | F11 | |||||
| holding | JNJ | Common Stock | 2,173 | 13 Feb 2026 | By 401k | F12 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | JNJ | Performance Share Units | Options Exercise | $0 | -37,463 | -100% | $0.000000 | 0 | 13 Feb 2026 | Common Stock | 37,463 | Direct | F1 | |
| transaction | JNJ | Restricted Share Units | Options Exercise | $0 | -1,779 | -100% | $0.000000 | 0 | 13 Feb 2026 | Common Stock | 1,779 | Direct | F3 | |
| transaction | JNJ | Restricted Share Units | Options Exercise | $0 | -1,971 | -50% | $0.000000 | 1,971 | 15 Feb 2026 | Common Stock | 1,971 | Direct | F5, F13 | |
| transaction | JNJ | Restricted Share Units | Options Exercise | $0 | -1,878 | -33% | $0.000000 | 3,754 | 15 Feb 2026 | Common Stock | 1,878 | Direct | F6, F13 | |
| transaction | JNJ | Employee Stock Options (Right to Buy) | Award | $0 | +53,793 | $0.000000 | 53,793 | 15 Feb 2026 | Common Stock | 53,793 | $243.45 | Direct | F14 | |
| transaction | JNJ | Restricted Share Units | Award | $0 | +3,863 | $0.000000 | 3,863 | 15 Feb 2026 | Common Stock | 3,863 | Direct | F13, F15 | ||
| transaction | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | $0 | -19,241 | -100% | $0.000000 | 0 | 17 Feb 2026 | Common Stock | 19,241 | $115.67 | Direct | F16 |
| transaction | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | $0 | -12,066 | -100% | $0.000000 | 0 | 17 Feb 2026 | Common Stock | 12,066 | $129.51 | Direct | F16 |
| transaction | JNJ | Employee Stock Options (Right to Buy) | Options Exercise | $0 | -33,386 | -50% | $0.000000 | 33,000 | 17 Feb 2026 | Common Stock | 33,386 | $131.94 | Direct | F16 |
| Id | Content |
|---|---|
| F1 | Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. |
| F2 | Shares withheld for payment of taxes upon vesting of PSUs. |
| F3 | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. |
| F4 | Shares withheld for payment of taxes upon vesting of RSUs. |
| F5 | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. |
| F6 | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. |
| F7 | This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F10 | This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F11 | Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary. |
| F12 | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026). |
| F13 | Each RSU represents a contingent right to receive one share of Company Common Stock. |
| F14 | Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. |
| F15 | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. |
| F16 | Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date. |